Comp En De Mn Cemig ADS American Depositary Shares (CIG)

Total Costs & Expenses

R$9.26B

Quarterly · Period ending: · BRL

CIG logo

CIG Total Costs & Expenses

Latest reportedR$9.26B BRL
CIG Quarterly Total Costs & Expenses · BRL (R$1.10B → R$9.26B)
High-resolution chart · PNG

CIG total costs & expenses history

Quarterly · BRL. Dates are reporting period ends; fiscal years can differ from calendar years.

Comp En De Mn Cemig ADS American Depositary Shares Total Costs & Expenses — Quarterly (BRL)
Period endingTotal Costs & Expenses (BRL)
9,256,880,000
9,520,241,000
10,772,671,000
9,503,802,000
9,287,501,000
8,350,496,000
9,659,807,000
8,683,737,000
6,908,519,000
7,436,040,000
8,147,010,000
7,732,133,000
7,243,846,000
6,787,632,000
13,784,038,000
7,721,311,000
8,147,706,000
6,214,544,000
8,287,589,000
7,898,000,000
5,005,525,000
5,503,843,000
5,956,604,000
5,191,344,000
3,879,766,000
5,493,615,000
0
6,354,788,000
5,453,411,000
4,682,712,000
5,471,749,000
6,252,282,000
5,016,076,000
4,140,988,000
6,558,219,000
5,241,236,000
4,674,822,000
3,914,061,000
4,666,262,000
2,478,659,000
4,352,609,000
3,951,281,000
5,130,358,000
4,336,801,000
4,347,480,000
4,343,850,000
4,793,193,000
3,490,384,000
3,401,217,000
3,112,154,000
10,439,104,000
-4,323,688,000
2,370,734,000
2,584,818,000
4,921,703,000
3,545,251,000
2,422,876,000
4,148,000,000
4,341,048,000
2,795,209,000
2,788,331,000
2,546,538,000
3,815,165,000
3,183,177,000
2,288,387,000
2,118,653,000
6,469,707,000
2,093,882,000
2,109,426,000
1,752,358,000
2,033,742,000
1,824,376,000
1,735,180,000
1,947,702,000
2,287,044,000
1,770,670,640
3,471,655,446
2,266,847,286
2,327,294,036
1,955,526,079
1,870,898,898
1,687,760,883
1,783,468,050
1,956,680,469
1,530,358,267
1,250,223,429
1,648,234,594
1,635,468,078
1,634,519,175
1,141,490,680
1,450,447,965
1,131,016,205
1,607,259,704
1,086,388,416
-1,692,399,445
2,412,462,140
1,506,178,545
871,344,292
2,616,270,481
1,104,056,803
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.